Bakersfield Memorial Hospital

Bakersfield Memorial Hospital was paid $170.75M by Medicaid between Jan 2018 and Dec 2024, across 332 billing codes. Its largest line is 99285, emergency room visit (most serious) — 30% of everything it billed.

33Billing provider infoBAKERSFIELD MEMORIAL HOSPITAL
BAKERSFIELD, CA 93301

33aNPI1467538520assigned 10/31/2006

33bProvider typeSkilled Nursing Facility

28Total paid$170.75M

24GClaims2,383,944

24DCodes billed332

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Skilled Nursing Facility providers in California

Rank by total paid#1 of 547

Median peer was paid$73K

This provider vs. median2,331×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	343,558	$22.21M
2019	321,973	$24.02M
2020	225,919	$17.30M
2021	286,470	$21.38M
2022	372,757	$25.72M
2023	438,512	$30.10M
2024incomplete	394,755	$30.01M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	30%	140,499	128,177	$51.57M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	27%	111,873	101,457	$45.47M
0450	Emergency room services	11%	80,939	72,062	$18.13M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	3.3%	4,227	3,970	$5.70M
0762		3.3%	5,782	2,658	$5.65M
J9271	Injection, pembrolizumab, 1 mg	2.0%	257	188	$3.45M
45384		1.6%	2,404	2,258	$2.81M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.4%	5,665	5,394	$2.44M
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.0%	1,404	1,315	$1.73M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,452	1,367	$1.60M
Z7502		<1%	37,464	36,791	$1.35M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	16,230	9,151	$1.22M

320 more codes

45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	648	$1.19M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	25,897	$1.13M
G0378	Hospital observation service, per hour	<1%	1,143	$931K
96367		<1%	12,719	$882K
70450	Computed tomography, head or brain; without contrast material	<1%	11,713	$826K
J1453	Injection, fosaprepitant, 1 mg	<1%	3,806	$794K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	52,504	$794K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	22,010	$754K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	6,127	$717K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	61,020	$685K
93458		<1%	355	$657K
Z9725		<1%	14,896	$641K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	11,260	$599K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	133,876	$561K
0360		<1%	2,049	$533K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,286	$522K
43450		<1%	506	$509K
0270		<1%	25,660	$459K
97802		<1%	3,546	$438K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,801	$429K
96361	Intravenous infusion, hydration; each additional hour	<1%	16,726	$425K
J0185	Injection, aprepitant, 1 mg	<1%	1,182	$404K
71046	Radiologic examination, chest; 2 views	<1%	34,213	$383K
43249		<1%	312	$382K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,231	$376K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	1,657	$362K
96375	Therapeutic injection; each additional sequential IV push	<1%	16,618	$360K
J3490	Unclassified drugs	<1%	50,265	$350K
80053	Comprehensive metabolic panel	<1%	59,607	$343K
80048	Basic metabolic panel (calcium, ionized)	<1%	72,594	$336K
J1750	Injection, iron dextran, 50 mg	<1%	3,207	$318K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	7,891	$317K
86803		<1%	38,721	$282K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,471	$272K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,228	$271K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,636	$256K
96368		<1%	9,806	$248K
J1644	Injection, heparin sodium, per 1000 units	<1%	26,565	$235K
84484		<1%	46,201	$227K
59025	Fetal non-stress test	<1%	10,509	$215K
0760		<1%	5,072	$209K
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	7,589	$192K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	784	$186K
47562		<1%	75	$182K
J7030	Infusion, normal saline solution , 1000 cc	<1%	27,650	$173K
96415		<1%	4,018	$172K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,245	$172K
86703		<1%	27,831	$162K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,017	$159K
97803		<1%	2,428	$156K
83690		<1%	40,824	$155K
J7050	Infusion, normal saline solution, 250 cc	<1%	20,372	$151K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	12,467	$148K
99070		<1%	216,947	$146K
96417		<1%	3,455	$145K
81001		<1%	65,354	$144K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,676	$140K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	24,232	$136K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	22,895	$134K
J1756	Injection, iron sucrose, 1 mg	<1%	1,705	$129K
71045	Radiologic examination, chest; single view	<1%	20,780	$128K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,548	$127K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,879	$114K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	417	$109K
80076		<1%	27,343	$106K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	8,801	$105K
87040		<1%	9,792	$102K
86592		<1%	49,397	$102K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,716	$101K
96523		<1%	4,190	$101K
0160		<1%	598	$100K
83880		<1%	6,764	$99K
87507		<1%	796	$99K
84703		<1%	15,200	$98K
99153	Mod sedat endo service >5yrs	<1%	7,710	$97K
0710		<1%	2,644	$96K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	8,394	$94K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,971	$87K
Z7610		<1%	16,783	$87K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	883	$81K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,963	$81K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	21,807	$78K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,022	$73K
84145		<1%	7,780	$72K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	15,655	$69K
0761		<1%	1,208	$69K
93971		<1%	1,326	$68K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	108	$68K
99152		<1%	1,267	$67K
82962		<1%	17,867	$67K
83605		<1%	8,934	$64K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,074	$62K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,738	$62K
84702		<1%	5,257	$59K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	748	$58K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	885	$58K
95700		<1%	273	$56K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,078	$54K
76819	Fetal biophysical profile; without non-stress testing	<1%	781	$53K
16020		<1%	438	$51K
85730		<1%	10,450	$51K
0250		<1%	4,960	$51K
81025		<1%	15,374	$50K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	10,657	$50K
76801		<1%	2,002	$48K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,099	$48K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,088	$48K
72100		<1%	2,775	$47K
0750		<1%	6,417	$46K
A9270	Non-covered item or service	<1%	2,845	$45K
87631		<1%	1,568	$45K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	263	$44K
J2785	Injection, regadenoson, 0.1 mg	<1%	899	$44K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,851	$43K
73130		<1%	1,955	$41K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,214	$41K
74018		<1%	4,678	$41K
73562		<1%	2,893	$41K
73610		<1%	2,469	$39K
73630		<1%	2,566	$39K
93976		<1%	203	$38K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	5,713	$37K
90715		<1%	1,000	$37K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	34	$37K
96411		<1%	1,423	$37K
87186		<1%	4,782	$35K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,769	$35K
85610		<1%	11,321	$35K
96376		<1%	651	$33K
83735		<1%	12,178	$33K
86923		<1%	1,037	$32K
70486		<1%	402	$32K
81003		<1%	19,111	$32K
99195		<1%	1,153	$31K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	35	$31K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,469	$31K
87077		<1%	6,434	$30K
C1769	Guide wire	<1%	341	$29K
73030		<1%	2,100	$29K
J9190	Injection, fluorouracil, 500 mg	<1%	1,209	$28K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	488	$28K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,174	$27K
36415	Collection of venous blood by venipuncture	<1%	20,349	$27K
96416		<1%	452	$27K
86901		<1%	7,264	$25K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	125	$25K
86140		<1%	6,591	$24K
85027		<1%	4,877	$24K
70496		<1%	331	$24K
95714		<1%	63	$23K
76870		<1%	808	$23K
87081		<1%	6,361	$23K
96402		<1%	1,419	$22K
Z7500		<1%	631	$21K
87070		<1%	2,206	$21K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,666	$19K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	888	$19K
70498		<1%	340	$19K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,306	$19K
73110		<1%	1,090	$18K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	249	$18K
86850		<1%	4,805	$18K
88312		<1%	3,203	$17K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	183	$17K
86900		<1%	5,776	$17K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,644	$15K
J1815	Injection, insulin, per 5 units	<1%	3,429	$15K
86635		<1%	1,504	$15K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	505	$15K
0324		<1%	225	$15K
99199	Unlisted special service, procedure or report	<1%	402	$14K
71020		<1%	271	$14K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	664	$14K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	157	$13K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,461	$13K
84443	Thyroid stimulating hormone (TSH)	<1%	2,289	$13K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	14	$13K
72040		<1%	905	$12K
0370		<1%	127	$12K
87522	Neg quan hep c or qual rna	<1%	1,547	$11K
97750		<1%	799	$11K
0097U		<1%	99	$11K
73090		<1%	597	$10K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,553	$10K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,476	$10K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,296	$10K
0301		<1%	67	$10K
73080		<1%	562	$9K
96111		<1%	87	$9K
93017		<1%	904	$9K
94644		<1%	1,086	$9K
82803		<1%	1,161	$9K
73140		<1%	764	$8K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	158	$8K
74019		<1%	838	$8K
73590		<1%	755	$8K
87205		<1%	1,829	$8K
82550		<1%	1,924	$8K
0258		<1%	1,657	$8K
J2704	Injection, propofol, 10 mg	<1%	2,174	$7K
73502		<1%	509	$7K
87147		<1%	725	$7K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,937	$7K
J1953	Injection, levetiracetam, 10 mg	<1%	553	$7K
93970		<1%	179	$6K
85379		<1%	1,833	$6K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	547	$6K
80061	Lipid panel	<1%	1,990	$6K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	641	$6K
J3489	Injection, zoledronic acid, 1 mg	<1%	166	$5K
82247		<1%	1,477	$5K
C1760	Closure device, vascular (implantable/insertable)	<1%	12	$5K
93975		<1%	72	$5K
82010		<1%	1,250	$5K
72131		<1%	90	$5K
36430		<1%	257	$5K
P9011	Blood, split unit	<1%	1,409	$5K
86780		<1%	2,094	$4K
J9045	Injection, carboplatin, 50 mg	<1%	98	$4K
C1726	Catheter, balloon dilatation, non-vascular	<1%	58	$4K
92611		<1%	17	$4K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	1,013	$4K
J2060	Injection, lorazepam, 2 mg	<1%	941	$4K
97804		<1%	77	$4K
82248		<1%	1,135	$4K
94664		<1%	440	$4K
Z4307		<1%	152	$4K
71101		<1%	270	$3K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	137	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	289	$3K
97162		<1%	387	$3K
85007		<1%	2,128	$3K
87210		<1%	1,382	$3K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	1,303	$3K
84100		<1%	2,356	$3K
86593		<1%	1,456	$3K
71010		<1%	68	$3K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	47	$3K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	651	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	388	$3K
73600		<1%	12	$2K
95711		<1%	14	$2K
85651		<1%	990	$2K
A9150	Non-prescription drugs	<1%	1,649	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	47	$2K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	698	$2K
J9267	Injection, paclitaxel, 1 mg	<1%	58	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	1,260	$2K
82140		<1%	476	$2K
0949		<1%	185	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	424	$2K
Z4302		<1%	104	$1K
71250		<1%	40	$1K
Z7514		<1%	27	$1K
S0028	Injection, famotidine, 20 mg	<1%	506	$1K
82805		<1%	273	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	221	$937.17
88313		<1%	108	$867.11
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	51	$839.79
97116		<1%	394	$837.97
J3370	Injection, vancomycin hcl, 500 mg	<1%	342	$832.92
88304		<1%	231	$821.90
84132		<1%	843	$815.16
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	91	$782.28
76830	Ultrasound, transvaginal	<1%	31	$754.54
0320		<1%	14	$697.78
86308		<1%	90	$667.08
87634		<1%	31	$650.00
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	164	$624.85
74000		<1%	16	$585.00
12011		<1%	12	$570.42
36591		<1%	608	$556.20
J2430	Injection, pamidronate disodium, per 30 mg	<1%	16	$544.45
J3480	Injection, potassium chloride, per 2 meq	<1%	132	$540.53
76775		<1%	13	$536.60
73620		<1%	45	$534.64
84112		<1%	55	$533.75
J0780	Injection, prochlorperazine, up to 10 mg	<1%	46	$478.39
76010		<1%	48	$463.65
84550		<1%	278	$451.96
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	81	$404.53
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	24	$400.52
73552		<1%	69	$395.65
87420		<1%	407	$346.46
85018		<1%	41	$325.85
29580		<1%	55	$290.00
87428		<1%	20	$253.58
90686		<1%	35	$206.43
J0736	Injection, clindamycin phosphate, 300 mg	<1%	145	$191.61
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	123	$169.10
80074		<1%	20	$161.94
72070		<1%	12	$149.55
80164		<1%	31	$143.32
84439		<1%	51	$129.47
J1171	Injection, hydromorphone, 0.1 mg	<1%	32	$123.23
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	90	$94.75
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	102	$91.04
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	22	$88.11
87340		<1%	86	$77.11
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	39	$65.54
74230		<1%	17	$63.72
J2470	Injection, pantoprazole sodium, 40 mg	<1%	197	$60.57
84466		<1%	38	$58.52
J0694	Injection, cefoxitin sodium, 1 gm	<1%	26	$40.44
83540		<1%	41	$30.12
72170		<1%	16	$20.15
J1836	Injection, metronidazole, 10 mg	<1%	25	$19.70
80051		<1%	12	$8.70
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	17	$0.00
97167		0%	59	$0.00
0258R		0%	165	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	17	$0.00
73000		0%	12	$0.00
A4218	Sterile saline or water, metered dose dispenser, 10 ml	0%	15	$0.00
0250R		0%	6,432	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	33	$0.00
72046		0%	15	$0.00
J0456	Injection, azithromycin, 500 mg	0%	44	$0.00
84436		0%	14	$0.00
70491		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAN BOENING, JON (PRESIDENT)